Filtered By:
Source: Cancer Journal
Vaccination: Cancer Vaccines
This page shows you your search results in order of date.
Order by Relevance | Date
Total 234 results found since Jan 2013.
A Brief Overview of Cancer Vaccines
Cancer J. 2023 Jan-Feb 01;29(1):34-37. doi: 10.1097/PPO.0000000000000640.ABSTRACTVaccine strategies for cancer differ from infectious disease in focusing mainly on clearing rather than preventing disease. Here we survey general vaccine strategies and combination therapy concepts being investigated for cancer treatment, with a focus on tumor antigens rather than cancer-inducing viruses or microorganisms. Many tumor antigens are "altered-self" and tend to arouse weaker immune responses than "foreign" antigens expressed by infectious agents. Further, unlike an infectious disease patient, a cancer patient's immune system is da...
Source: Cancer Journal - January 24, 2023 Category: Cancer & Oncology Authors: Alexander J Muller Sunil Thomas George C Prendergast Source Type: research
Impact of Precision Medicine in Oncology: Immuno-oncology
Cancer J. 2023 Jan-Feb 01;29(1):15-19. doi: 10.1097/PPO.0000000000000641.ABSTRACTCancer treatment has dramatically changed over the last decade with the development of immunotherapy. Therapies including immune cytokines, immune checkpoint inhibition, intratumoral therapies, and cellular therapies are already widely used in the oncology clinic. Active development continues in these areas and in the development of vaccines, bispecific therapies, and more refined cellular therapies. In this review, we will examine the role that immune therapy has in cancer treatment and explore areas of future development.PMID:36693153 | DOI:...
Source: Cancer Journal - January 24, 2023 Category: Cancer & Oncology Authors: Elizabeth I Buchbinder F Stephen Hodi Source Type: research
A Brief Overview of Cancer Vaccines
Cancer J. 2023 Jan-Feb 01;29(1):34-37. doi: 10.1097/PPO.0000000000000640.ABSTRACTVaccine strategies for cancer differ from infectious disease in focusing mainly on clearing rather than preventing disease. Here we survey general vaccine strategies and combination therapy concepts being investigated for cancer treatment, with a focus on tumor antigens rather than cancer-inducing viruses or microorganisms. Many tumor antigens are "altered-self" and tend to arouse weaker immune responses than "foreign" antigens expressed by infectious agents. Further, unlike an infectious disease patient, a cancer patient's immune system is da...
Source: Cancer Journal - January 24, 2023 Category: Cancer & Oncology Authors: Alexander J Muller Sunil Thomas George C Prendergast Source Type: research
Impact of Precision Medicine in Oncology: Immuno-oncology
Cancer J. 2023 Jan-Feb 01;29(1):15-19. doi: 10.1097/PPO.0000000000000641.ABSTRACTCancer treatment has dramatically changed over the last decade with the development of immunotherapy. Therapies including immune cytokines, immune checkpoint inhibition, intratumoral therapies, and cellular therapies are already widely used in the oncology clinic. Active development continues in these areas and in the development of vaccines, bispecific therapies, and more refined cellular therapies. In this review, we will examine the role that immune therapy has in cancer treatment and explore areas of future development.PMID:36693153 | DOI:...
Source: Cancer Journal - January 24, 2023 Category: Cancer & Oncology Authors: Elizabeth I Buchbinder F Stephen Hodi Source Type: research
A Brief Overview of Cancer Vaccines
Cancer J. 2023 Jan-Feb 01;29(1):34-37. doi: 10.1097/PPO.0000000000000640.ABSTRACTVaccine strategies for cancer differ from infectious disease in focusing mainly on clearing rather than preventing disease. Here we survey general vaccine strategies and combination therapy concepts being investigated for cancer treatment, with a focus on tumor antigens rather than cancer-inducing viruses or microorganisms. Many tumor antigens are "altered-self" and tend to arouse weaker immune responses than "foreign" antigens expressed by infectious agents. Further, unlike an infectious disease patient, a cancer patient's immune system is da...
Source: Cancer Journal - January 24, 2023 Category: Cancer & Oncology Authors: Alexander J Muller Sunil Thomas George C Prendergast Source Type: research
Impact of Precision Medicine in Oncology: Immuno-oncology
Cancer J. 2023 Jan-Feb 01;29(1):15-19. doi: 10.1097/PPO.0000000000000641.ABSTRACTCancer treatment has dramatically changed over the last decade with the development of immunotherapy. Therapies including immune cytokines, immune checkpoint inhibition, intratumoral therapies, and cellular therapies are already widely used in the oncology clinic. Active development continues in these areas and in the development of vaccines, bispecific therapies, and more refined cellular therapies. In this review, we will examine the role that immune therapy has in cancer treatment and explore areas of future development.PMID:36693153 | DOI:...
Source: Cancer Journal - January 24, 2023 Category: Cancer & Oncology Authors: Elizabeth I Buchbinder F Stephen Hodi Source Type: research
A Brief Overview of Cancer Vaccines
Cancer J. 2023 Jan-Feb 01;29(1):34-37. doi: 10.1097/PPO.0000000000000640.ABSTRACTVaccine strategies for cancer differ from infectious disease in focusing mainly on clearing rather than preventing disease. Here we survey general vaccine strategies and combination therapy concepts being investigated for cancer treatment, with a focus on tumor antigens rather than cancer-inducing viruses or microorganisms. Many tumor antigens are "altered-self" and tend to arouse weaker immune responses than "foreign" antigens expressed by infectious agents. Further, unlike an infectious disease patient, a cancer patient's immune system is da...
Source: Cancer Journal - January 24, 2023 Category: Cancer & Oncology Authors: Alexander J Muller Sunil Thomas George C Prendergast Source Type: research
Impact of Precision Medicine in Oncology: Immuno-oncology
Cancer J. 2023 Jan-Feb 01;29(1):15-19. doi: 10.1097/PPO.0000000000000641.ABSTRACTCancer treatment has dramatically changed over the last decade with the development of immunotherapy. Therapies including immune cytokines, immune checkpoint inhibition, intratumoral therapies, and cellular therapies are already widely used in the oncology clinic. Active development continues in these areas and in the development of vaccines, bispecific therapies, and more refined cellular therapies. In this review, we will examine the role that immune therapy has in cancer treatment and explore areas of future development.PMID:36693153 | DOI:...
Source: Cancer Journal - January 24, 2023 Category: Cancer & Oncology Authors: Elizabeth I Buchbinder F Stephen Hodi Source Type: research
A Brief Overview of Cancer Vaccines
Cancer J. 2023 Jan-Feb 01;29(1):34-37. doi: 10.1097/PPO.0000000000000640.ABSTRACTVaccine strategies for cancer differ from infectious disease in focusing mainly on clearing rather than preventing disease. Here we survey general vaccine strategies and combination therapy concepts being investigated for cancer treatment, with a focus on tumor antigens rather than cancer-inducing viruses or microorganisms. Many tumor antigens are "altered-self" and tend to arouse weaker immune responses than "foreign" antigens expressed by infectious agents. Further, unlike an infectious disease patient, a cancer patient's immune system is da...
Source: Cancer Journal - January 24, 2023 Category: Cancer & Oncology Authors: Alexander J Muller Sunil Thomas George C Prendergast Source Type: research
Impact of Precision Medicine in Oncology: Immuno-oncology
Cancer J. 2023 Jan-Feb 01;29(1):15-19. doi: 10.1097/PPO.0000000000000641.ABSTRACTCancer treatment has dramatically changed over the last decade with the development of immunotherapy. Therapies including immune cytokines, immune checkpoint inhibition, intratumoral therapies, and cellular therapies are already widely used in the oncology clinic. Active development continues in these areas and in the development of vaccines, bispecific therapies, and more refined cellular therapies. In this review, we will examine the role that immune therapy has in cancer treatment and explore areas of future development.PMID:36693153 | DOI:...
Source: Cancer Journal - January 24, 2023 Category: Cancer & Oncology Authors: Elizabeth I Buchbinder F Stephen Hodi Source Type: research
A Brief Overview of Cancer Vaccines
Cancer J. 2023 Jan-Feb 01;29(1):34-37. doi: 10.1097/PPO.0000000000000640.ABSTRACTVaccine strategies for cancer differ from infectious disease in focusing mainly on clearing rather than preventing disease. Here we survey general vaccine strategies and combination therapy concepts being investigated for cancer treatment, with a focus on tumor antigens rather than cancer-inducing viruses or microorganisms. Many tumor antigens are "altered-self" and tend to arouse weaker immune responses than "foreign" antigens expressed by infectious agents. Further, unlike an infectious disease patient, a cancer patient's immune system is da...
Source: Cancer Journal - January 24, 2023 Category: Cancer & Oncology Authors: Alexander J Muller Sunil Thomas George C Prendergast Source Type: research
Impact of Precision Medicine in Oncology: Immuno-oncology
Cancer J. 2023 Jan-Feb 01;29(1):15-19. doi: 10.1097/PPO.0000000000000641.ABSTRACTCancer treatment has dramatically changed over the last decade with the development of immunotherapy. Therapies including immune cytokines, immune checkpoint inhibition, intratumoral therapies, and cellular therapies are already widely used in the oncology clinic. Active development continues in these areas and in the development of vaccines, bispecific therapies, and more refined cellular therapies. In this review, we will examine the role that immune therapy has in cancer treatment and explore areas of future development.PMID:36693153 | DOI:...
Source: Cancer Journal - January 24, 2023 Category: Cancer & Oncology Authors: Elizabeth I Buchbinder F Stephen Hodi Source Type: research
A Brief Overview of Cancer Vaccines
Cancer J. 2023 Jan-Feb 01;29(1):34-37. doi: 10.1097/PPO.0000000000000640.ABSTRACTVaccine strategies for cancer differ from infectious disease in focusing mainly on clearing rather than preventing disease. Here we survey general vaccine strategies and combination therapy concepts being investigated for cancer treatment, with a focus on tumor antigens rather than cancer-inducing viruses or microorganisms. Many tumor antigens are "altered-self" and tend to arouse weaker immune responses than "foreign" antigens expressed by infectious agents. Further, unlike an infectious disease patient, a cancer patient's immune system is da...
Source: Cancer Journal - January 24, 2023 Category: Cancer & Oncology Authors: Alexander J Muller Sunil Thomas George C Prendergast Source Type: research
Impact of Precision Medicine in Oncology: Immuno-oncology
Cancer J. 2023 Jan-Feb 01;29(1):15-19. doi: 10.1097/PPO.0000000000000641.ABSTRACTCancer treatment has dramatically changed over the last decade with the development of immunotherapy. Therapies including immune cytokines, immune checkpoint inhibition, intratumoral therapies, and cellular therapies are already widely used in the oncology clinic. Active development continues in these areas and in the development of vaccines, bispecific therapies, and more refined cellular therapies. In this review, we will examine the role that immune therapy has in cancer treatment and explore areas of future development.PMID:36693153 | DOI:...
Source: Cancer Journal - January 24, 2023 Category: Cancer & Oncology Authors: Elizabeth I Buchbinder F Stephen Hodi Source Type: research
